Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
The Canadian Journal of Cardiology|April 27, 2013
From bad behaviour to bad biology: pitfalls and promises in the management of resistant hypertensionRoss D Feldman, Eric P Brass
Annual Review of Pharmacology and Toxicology|November 5, 2016
GPER (GPR30): A Nongenomic Receptor (GPCR) for Steroid Hormones with Implications for Cardiovascular Disease and CancerRoss D Feldman, Lee E Limbird
The Canadian Journal of Cardiology|April 2, 2014
β-adrenoceptors as molecular targets in the treatment of hypertensionStephen S G Ferguson, Ross D Feldman
The Canadian Journal of Cardiology|May 5, 2015
Metabolic Syndrome Sinkholes: What to Do When Occam's Razor Gets BluntedRoss D Feldman, Todd J Anderson, Rhian M Touyz
The Canadian Journal of Cardiology|June 13, 2008
Canadian Hypertension Education Program: the evolution of hypertension management guidelines in CanadaRoss D Feldman, Norman R C Campbell, Katherine Wyard
The Canadian Journal of Cardiology|September 21, 2023
Revising the Roles of Aldosterone in Vascular Physiology and Pathophysiology: From Electocortin to BaxdrostatRoss D Feldman, Rohan Sanjanwala, Raj Padwal, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 21, 2011
Choreographing the adenylyl cyclase signalosome: sorting out the partners and the stepsRennolds S Ostrom, Amy S Bogard, Robert Gros, et al.
American Journal of Physiology. Cell Physiology|January 4, 2013
Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activationRobert Gros, Qingming Ding, Bonan Liu, et al.
Annual Review of Pharmacology and Toxicology|September 25, 2014
Mineralocorticoids in the heart and vasculature: new insights for old hormonesAchim Lother, Martin Moser, Christoph Bode, et al.
The Canadian Journal of Cardiology|April 30, 2019
The History of Hypertension Guidelines in CanadaStella S Daskalopoulou, Ross D Feldman, Finlay A McAlister, et al.
Pageof 8